IP
IPCA Labs
IPCALAB.NS·NSEMumbai INFounded 19499,000 employees
Mid CappharmaPublicInfectious DiseaseMetabolic
Platform: API Formulations
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (IPCALAB.NS)
Loading IPCALAB.NS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IPC-884 | IPC-884 | Approved | 3 | MET | MDSNMOSD | ||
| Elrasacituzumab | IPC-5839 | Phase 2/3 | 1 | EGFR | FabryOvarian Ca | ||
| Datocagene | IPC-3838 | Phase 2 | 2 | Aβ | SCLCIgAN |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
IPCA Labs trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (7)